Histiocytomas are common in dogs and account for 3%-14% of canine skin tumors
Cause unknown
Intracytoplasmic reticular aggregates are suggestive of a viral cause but a causative agent has not been identified and experimental horizontal transmission has been unsuccessful
Histiocytomas arise from epidermotrophic Langerhans cells in the skin and are different from the macrophage immunophenotype
Histiocyte proliferation expresses major histocompatability complex class II and several leukocyte antigens characteristic of dendritic cell differentiation
+ Clinical Features
Age: 50% < 2 years
Breed predisposition: Boxer, Dachshund, Cocker Spaniel, Great Dane, Shetland Sheepdog, and Bull Terrier
Sites: head (especially pinna), pelvic limb, feet, and trunk
Benign tumor despite rapid growth and high mitotic index
Nucleus variable in size and shape, cytoplasm pale blue, and lymphocytic, plasmocytic, or neutrophilic infiltrates
Spontaneous regression possible with concurrent lymphoid infiltration which is mediated by CD8+ T cells
Treatment: surgery or cryosurgery
Prognosis: excellent
+ Cutaneous Histiocytosis
Cutaneous histiocytosis: benign proliferation of multiple erythematous dermal or subcutaneous plaques or nodules
Spontaneous asynchronous regression over 8-12 weeks
Treatment: corticosteroids ± azathioprine and polyethylene glycosylated L-asparaginase
Malignant fibrous histiocytoma is a diagnosis that is being phased out in both veterinary and human pathology
Primitive, pleomorphic sarcomas arising from undifferentiated mesenchymal cells
Storiform-pleomorphic subtype is most common in dogs and giant cell subtype is most common in cats
Histiogenesis of malignant fibrous histiocytoma is controversial and may represent final common pathway of tumor progression (for both STS and other tumor types) or misdiagnosis as histologic re-evaluation of malignant fibrous histiocytoma in humans has demonstrated many different histologic types
Mean age 8-9 years (but reported in 4-month-old puppy)
Breed predisposition: Flat-Coated Retrievers
Biologic behaviour: invasive with high recurrence rate and moderate metastatic potential dependent on tumor grade
Malignant fibrous histiocytoma has also been reported in the cat with the same biologic behaviour
Gross appearance: firm and invasive arising from subcutis
Histologic DDx: FSA, peripheral nerve sheath tumor, and extraskeletal OSA
Prognosis is guarded as majority are grade III tumors with no response to either chemotherapy or radiation therapy
Giant cell variant of malignant fibrous histiocytoma has a 70% metastatic rate at diagnosis and overall metastatic rate of 90% with an overall MST 61 days and MST 161 days for treated dogs
Metastatic predictors in humans: histologic grade
+ Systemic Histiocytosis
Breed predisposition: familial disease in middle-aged Bernese Mountain Dog
Mean age 4 years
Prolonged course of disease with a mean of 15 months
Histiocytic infiltrates do not demonstrate clinical signs of malignancy
Predilection for skin, eyes, and lymph nodes
Skin lesions on flanks, muzzle, nasal planum, eyelids, and scrotum
Poorly responsive to anti-inflammatory and immunosuppressive therapy
Neoplastic transformation of tissue macrophages leading to excessive phagocytosis of erythrocytes
Breed predisposition: Bernese Mountain Dog, Golden Retriever, and Rottweiler
Familial disease in older Bernese Mountain Dog with probable polygenic mode of inheritance
Sex predilection: male
Mean age: 7 years (range, 4-10 years)
Rapidly fatal condition with relatively non-specific clinical signs such as weight loss, splenomegaly, hepatomegaly, dyspnea, neurologic signs, and severe regenerative anemia
Necropsy findings: multiple, solid, pale tumors in a variety of organs including spleen, liver, lymph node, and lungs
Malignant histiocytosis resembles anaplastic tumors and lysosome immunoreactivity can be used to differentiate systemic and malignant histiocytosis from other histiocytic disorders